SOURCE: Xtalks

Xtalks Webinars

October 19, 2015 07:00 ET

Achieving Effective Hematological Oncology Clinical Trials, New Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - October 19, 2015) - This free webinar examines the nuances of successfully conducting hematological oncology clinical trials. The live broadcast on Tuesday, November 3, 2015 at 2pm EST, features industry experts Ray Reilly, Senior Director, Oncology Division at Novella Clinical, and Richard Gams, MD, Chief Scientific Officer at Novella Clinical as the presenters.

Hematological malignancies such as leukemia, multiple myeloma and lymphoma represent a subset of indications within oncology that are wholly different from solid tumors. The growing hematological oncology therapy market is fueling both large numbers of clinical studies and, more importantly, an enhanced and refined understanding of cancer pathologies. Conducting clinical trials in hematological malignancies requires an understanding of a rapidly evolving treatment paradigm that is increasingly nuanced, complex and patient-directed. Companies developing hematological oncology therapies must capitalize on the principles and infrastructures shared by solid tumor oncology trials while adapting endpoints, study designs and data management approaches as well as considering patients' experiences to address the particular challenges related to investigating candidate treatments for blood-based cancers.

Join this webinar to gain an understanding of critical differences between solid tumor and hematological oncology and a discussion on the nuances of conducting successful hematological oncology clinical trials.

Learning Objectives

  • Understand critical trial design considerations; including tumor type, standard of care vs. research interests, and overall data capture nuances
  • Learn how to create meaningful, measurable endpoints and how they differ from solid tumor oncology studies
  • Recognize how to effectively monitor and manage data and queries within hematology oncology studies
  • Gain insight into selecting ideal trial sites for rare hematological malignancies and the importance of working with an oncology-experienced team

To register or learn more about this one-hour complimentary webinar visit: Achieving Effective Hematological Oncology Clinical Trials

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2015/10/16/11G067915/Images/V-Novella_Clinical-4C-831863263649.jpg

Contact Information